RARE-21. A DESCRIPTIVE REPORT OF PATIENTS WITH RARE CENTRAL NERVOUS SYSTEM (CNS) CANCERS ON AN NCI-CONNECT CANCER MOONSHOT IMMUNE CHECKPOINT INHIBITOR TRIAL

BACKGROUND: There is increasing interest in the use of immunotherapy in rare CNS tumors, but limited experiences in the clinical evaluation of imaging findings and treatment toxicity in these patients. A phase II clinical trial of Nivolumab, a PD-1 inhibitor, in eleven rare CNS tumors was developed...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Boris, Lisa, Bryla, Christine, Vera, Elizabeth, Aboud, Orwa, Garren, Nancy, Park, Deric, Siegel, Christine, Theeler, Brett, Wu, Jing, Armstrong, Terri, Gilbert, Mark
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2018
Matèries:
Abstracts
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6217685/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.995
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars